Don’t miss the latest developments in business and finance.

Jubilant Life Sciences receives final approval for Olmesartan Medoxomil Tablets

Image
Capital Market
Last Updated : Apr 26 2017 | 12:02 AM IST

From USFDA

Jubilant Life Sciences has received from USFDA Abbreviated New Drug Application final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

Powered by Capital Market - Live News

Also Read

First Published: Apr 25 2017 | 11:08 AM IST

Next Story